Skip to content

Efficacy of an online intervention for anxiety prevention: A clinical trial

Leonardo Júnior Souza Silva, Raíssa Ester Maia Monteiro, Danilo Andrade de Meneses, Ighor Domingos Bandeira, Luiz Carlos Serramo Lopez

Psicologia - Teoria e Prática 2023 DOI: 10.5935/1980-6906/eptpcp15070.en (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Randomized controlled trial Peer reviewed
Sample size 48
Population Brazilian university students
Duration 4-week intervention, 4-week follow-up
Topics Anxiety
Citations 5
Key findings The authors report that a four-week mindfulness intervention delivered via a mobile application significantly reduced anxiety at four-week follow-up compared with a waiting-list control group, with a large effect size (F(2, 92) = 10.275, eta-squared = 0.183). They suggest the intervention acted as a protective factor against anxiety during the COVID-19 pandemic, as the treatment group maintained reduced anxiety while the control group's anxiety increased.

Abstract

This study aimed to test the effectiveness and the sustained effect (follow-up) of a four-week mindfulness intervention in reducing anxiety and stress in a group of Brazilian university students.The intervention was adapted to be made available through the Neurosaúde application, created as part of this work to serve as a platform for the intervention.The research took place in a virtual environment, with 48 participants recruited, who were randomly allocated to the intervention group or to the waiting list control group.Measures were used to access the levels of mindfulness, anxiety, and stress before and after the intervention and at the 4-week follow-up.Applying the intention-to-treat analysis, we found significant differences between the groups regarding the measurement of anxiety in the follow-up, with a large effect size (F(2, 92) = 10.275,p = .000,η 2 = 0.183).The results suggest that the 4-week mindfulness intervention through a mobile application was able to act as a protective factor against the anxiety developed by university students during the COVID-19 pandemic.While the treatment group maintained reduced levels of anxiety the control group demonstrated a continuous increase in anxiety in the post-test and follow-up that coincided with the first wave of COVID-19 in the region where the participants lived.

Comparable studies

Other randomized controlled trials on anxiety, most cited first.

Study Year Design Participants
Prevention of relapse/recurrence in major depression by mindfulness-based cognitive therapy. Recovered recurrently depressed patients 2000 Randomized controlled trial n = 145
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Cancer patients with life-threatening diagnoses and symptoms of depression and/or anxiety 2016 Randomized controlled trial n = 51
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Patients with cancer-related anxiety and depression 2016 Double-blind, placebo-controlled, crossover trial n = 29
Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance Hallucinogen-naïve adults reporting regular participation in religious or spiritual... 2006 Double-blind study n = 36
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Adults with advanced-stage cancer and anxiety 2010 Double-blind, placebo-controlled study n = 12

Citations in the library

Explore topics